Results 111 to 120 of about 9,148 (176)

Osteolysis After Interphalangeal Joint Arthrodesis in Systemic Sclerosis: A Case Series. [PDF]

J Rheumatol
Mathias KR, Grandison J, Lifchez SD, Wigley F.   +3 more
europepmc   +1 more source

Association of Black Race With Demographic, Comorbidities, and Outcome Variables in Localized Scleroderma Patients: A Retrospective Analysis of the 2017 US National Inpatient Sample

Dermatology Practical & Conceptual
Keshav D. Kumar, Amar D. Desai, Shari R Lipner   +2 more
doaj   +1 more source

Janus kinase inhibitors in localized scleroderma: a systematic literature review. [PDF]

Turk J Med Sci
Şener S, Şener YZ, Batu ED, Sari A, Akdoğan A.   +4 more
europepmc   +1 more source

Prevalence and severity of complicated Raynaud's phenomenon in limited and diffuse systemic sclerosis: a multicenter study in Iraq. [PDF]

Reumatologia
Jaafar F, Moayad Z, Gorial F, Alkazzaz A.   +3 more
europepmc   +1 more source

The Therapeutic Effects of Semaglutide in Congenital Linear Scleroderma. [PDF]

Cureus
Chen H, Elhawi M, Tarbox M.
europepmc   +1 more source

Calcinosis Cutis Universalis: A Review of Therapeutic Strategies and Surgical Management. [PDF]

J Clin Med
Giacometti E, Martineau J, Petrou IG, Kalbermatten DF, Scampa M.   +4 more
europepmc   +1 more source

Devastating neurologic consequences of localized scleroderma en coup de sabre of the scalp-2 case studies. [PDF]

J Scleroderma Relat Disord
Ma C, Legault K, Provias J, Zhang E, Gallienne C, Larche M.   +5 more
europepmc   +1 more source

Esomeprazole inhibits proliferation of scleroderma fibroblasts via cell cycle regulation. [PDF]

Front Pharmacol
Khan MA, Koniyan S, Ahir M, Jegga AG, Mayes MD, Gius D, Leung J, Bonnen MD, Montesi SB, Ghebre YT.   +9 more
europepmc   +1 more source

Anti-Ku Antibodies in a Patient With a Polymyositis-Systemic Sclerosis Overlap Syndrome in Association With Autoimmune Hepatitis. [PDF]

Cureus
Zubair M, Wazir M, Ullah F, Thomson SJ, Hepburn A.   +4 more
europepmc   +1 more source

Clinical characteristics, autoantibody profiles, and therapeutic outcomes of juvenile systemic sclerosis: an 11-year single-center experience from China. [PDF]

Front Immunol
Wang Y, Tang W, Zhang Y, Zhang Z, An Y, Tang X.   +5 more
europepmc   +1 more source